Clinical trial
Inflammatory Resolution in Cardiometabolic Health and Disease
Recruiting now · Not applicable · 1 countries · Registry ID NCT06390189
What this study is about
The specific aim of this study is to determine molecular pathways that differentiate metabolically healthy vs unhealthy human phenotypes, and to investigate the therapeutic potential of pro-resolving lipids. Investigators will recruit volunteers that are metabolically healthy or unhealthy that fall within three BMI ranges: lean (18.-24.9 kg/m2), overweight (25.0-29.9 kg/m2) and obese (\>30.0 kg/m2). Investigators hypothesize that metabolically healthy individuals have a superior endogenous capacity to regulate an inflammatory/resolving response.
Basic eligibility
Full registry criteria
Treatments and study arms
Primary outcomes
Quantifiable inflammatory resolution by measurement of IL-6 cytokine levels in the acute vs the resolving phase of blister formation.
Study locations
1 locations were listed when this page was built. The first 40 are shown.